Portola Pharmaceuticals Inc. announced the FDA has approved Bevyxxa (betrixaban), the first and only anticoagulant for hospital and extended duration...
Portola Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...
Portola Pharmaceuticals Inc.'s Factor Xa inhibitor betrixaban's future in the EU is looking uncertain after the EMA's CHMP issued a...